QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
From Nordic registers to pragmatic clinical trials
Last week, our Senior Project Lead, Kelsi Smith, was invited to speak at the Singapore Clinical Research Institute (SCRI) Clinical Trials Symposium 2026.
Kelsi joined the session on Pragmatic Clinical Trials and Real-World Evidence, alongside an expert panel of researchers and industry specialists.
Her presentation explored register-based randomized trials and how they may support evidence generation across […]
Quantify Research at ISPE 2026 in Milan
Kirk Geale, PhD and Jessica Young will represent Quantify Research at the 42nd ISPE Annual Meeting, from 29 August to 2 September 2026.
This year’s theme, Unlocking the Power of Pharmacoepidemiology to Improve Patient Health, closely reflects our work.
Real world evidence supports evidence generation throughout the product lifecycle.
Before approval, RWE helps characterise disease burden, treatment patterns, and unmet need, sharpening our understanding […]
Pragmatic trials and RWE in focus at SCRI 2026
We are pleased to share that Kelsi Smith, Senior Project Lead, Real-World Evidence and Analytics at Quantify Research, will be speaking at the Singapore Clinical Research Institute (SCRI) Trials Symposium 2026 in Singapore.
Kelsi will join the session as one of the guest speakers:
Pragmatic & Real-World Evidence Studies
📅 30 July | 15:00–16:30
📍 Track 3: Innovations in Trial Design & Methodology
The session will explore how […]
JCA learnings: Sharing expertise across the athagoras Group
Our Market Access Strategy unit recently held a workshop focused on Joint Clinical Assessment (JCA) learnings.
The session brought together perspectives from Quantify Research and our sister companies within the athagoras Group creating a valuable opportunity to learn from practical experience in JCA dossier preparation and strategy.
Together, we explored:
📌key considerations in preparing a JCA dossier
📌 how evidence planning connects to access strategy
📌 learnings from […]
